Randomised aspirin assignment and risk of adult-onset asthma in the Women's Health Study

Kurth, I.; Barr, A. G.; Gaziano, J. M.; Buring, J. E.; Kurth, T; Barr, R G
June 2008
Thorax;Jun2008, Vol. 63 Issue 6, p514
Academic Journal
journal article
Background: Randomised data in men show a small but significant reduction in the risk of adult-onset asthma among those given aspirin. The results from an observational study in women suggest that frequent use of aspirin decreases the risk of adult-onset asthma, but randomised data in women are lacking. A study was undertaken to test the effect of 100 mg aspirin or placebo on alternate days on the risk of adult-onset asthma in the Women's Health Study.Methods: A randomised, double-blind, placebo-controlled clinical trial of aspirin and vitamin E was performed in apparently healthy women with no indication or contraindication to aspirin therapy and no history of asthma at study entry. Female health professionals self-reported an asthma diagnosis on yearly questionnaires.Results: Among 37 270 women with no reported history of asthma prior to randomisation and during 10 years of follow-up, there were 872 new cases diagnosed with asthma in the aspirin group and 963 in the placebo group (hazard ratio 0.90; 95% CI 0.82 to 0.99; p = 0.027). This apparent 10% lower relative risk of incident adult-onset asthma among those assigned to aspirin was significantly modified by body mass index, with no effect in women with a body mass index of >/=30 kg/m2. The effect of aspirin on adult-onset asthma was not significantly modified by age, smoking status, exercise levels, postmenopausal hormone use or randomised vitamin E assignment.Conclusions: In this large randomised clinical trial of apparently healthy adult women, administration of 100 mg aspirin on alternate days reduced the relative risk of a newly reported diagnosis of asthma.


Related Articles

  • Aspirin and dipyridamole for the secondary prevention of stroke. Zielinski, Rafal; French, Linda // Journal of Family Practice;Feb1999, Vol. 48 Issue 2, p92 

    The article cites a research study that investigates whether low-dose acetylsalicylic acid (ASA) or modified-release dipyridamole are efficacious in secondary prevention of ischemic stroke. The Second European Stroke Prevention Study (ESPS-2) was a randomized double-blind clinical trial of...

  • Meta-Analysis: Effect of Long-Acting β-Agonists on Severe Asthma Exacerbations and Asthma-Related Deaths. Salpeter, Shelley R.; Buckley, Nicholas S.; Ormiston, Thomas M.; Salpeter, Edwin E. // Annals of Internal Medicine;6/20/2006, Vol. 144 Issue 12, p904 

    Background: Long-acting β-agonists may increase the risk for fatal and nonfatal asthma exacerbations. Purpose: To assess the risk for severe, life-threatening, or fatal asthma exacerbations associated with long-acting β-agonists. Data Sources: English- and non-English-language searches of...

  • ATLAS TIMI 46: Rivaroxaban did not lower endpoint of death, MI, stroke, severe ischemia requiring revascularization.  // Cardiology Today;Dec2008, Vol. 11 Issue 12, p19 

    The article focuses on the results of the phase-2 ATLAS TIMI 46 trial participated by 3,491 patients who were receiving either aspirin alone or aspirin plus clopidogrel who then received rivaroxaban once daily or twice daily at the same dosing levels or placebo. Results showed that rivaroxaban...

  • Review: inhaled corticosteroids reduce wheezing and asthma exacerbations in infants and preschool children. Renouf, Paula // Evidence Based Nursing;Oct2009, Vol. 12 Issue 4, p2 

    The article discusses a study on the use of inhaled corticosteroids (ICSs) in infants and preschool children with wheezing/asthma. Randomized controlled trials (RCTs) were conducted, with patients being given either ICS or placebo. Outcomes include increase severity of wheezing/asthma...

  • The influence of gender on the effects of aspirin in preventing myocardial infarction. Yerman, Todd; Gan, Wen Q.; Sin, Don D. // BMC Medicine;2007, Vol. 5, p29 

    Background: There is considerable variation in the effect of aspirin therapy reducing the risk of myocardial infarction (MI). Gender could be a potential explanatory factor for the variability. We conducted a systematic review and meta-analysis to determine whether gender mix might play a role...

  • CLINICAL TRIAL DIGEST.  // Pulmonary Reviews;Mar2007, Vol. 12 Issue 3, p26 

    The article provides information on several clinical trials of treatments for various diseases. Intranasal ciclesonide or placebo will be given to adults and adolescents with at least two-year history of perennial allergic rhinitis. 220 children ages 2 to 14 with intermittent asthma were...

  • Is there a place for placebo controlled trials of antiepileptic drugs? Shorvon, S.D.; Espir, M.L.E.; Steiner, T.J.; Dellaportas, C.I.; Rose, F. Clifford // British Medical Journal (Clinical Research Edition);11/9/1985, Vol. 291 Issue 6505, p1328 

    Examines the possibility of a placebo controlled trials on antiepileptic drugs in Great Britain. Uncertainty on the role of anticonvulsant drugs on epileptics; Impact of epileptic seizures on the psychology and social behavior of epileptics; Natural history of epilepsy.

  • Withholding Proven Treatment in Clinical Research. Huston, Patricia; Peterson, Robert // New England Journal of Medicine;9/20/2001, Vol. 345 Issue 12, p912 

    Editorial. Discusses the ethics of placebo-controlled clinical trials. Role of the Declaration of Helsinki; Need for scientific and ethical justification of the use of placebos.

  • Is the Placebo Powerless? Hróbjartsson, Asbjørn; Gøtzsche, Peter C. // New England Journal of Medicine;05/24/2001, Vol. 344 Issue 21, p1594 

    Background: Placebo treatments have been reported to help patients with many diseases, but the quality of the evidence supporting this finding has not been rigorously evaluated. Methods: We conducted a systematic review of clinical trials in which patients were randomly assigned to either...


Read the Article


Sign out of this library

Other Topics